Kodiak Sciences (KOD) Convertible Debt (2017 - 2018)
Kodiak Sciences (KOD) posted Convertible Debt of $41.5 million for Q3 2018, up 318.06% on a QoQ basis from $9.9 million in Q4 2017.
Kodiak Sciences (KOD) Convertible Debt (2017 - 2018) Analysis & Trends
Kodiak Sciences' Convertible Debt history runs 2 years deep, the most recent figure standing at $41.5 million for Q3 2018.
- Quarterly Convertible Debt changed N/A year-over-year to $41.5 million in Q3 2018, while the trailing twelve-month figure through Sep 2018 was $41.5 million (changed N/A YoY) and the FY2017 annual result came in at $9.9 million, changed N/A from the prior year.
- Convertible Debt was $41.5 million for Q3 2018 at Kodiak Sciences, up from $9.9 million in the prior quarter.
- Across five years, Convertible Debt topped out at $41.5 million in Q3 2018 and bottomed at $9.9 million in Q4 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Kodiak Sciences | 2.54 Bn | 2.54 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2018 | 41.48 Mn |
| Dec 31, 2017 | 9.92 Mn |